Explosion in mortality in the Amazonian epicenter of the COVID-19 epidemic 19

Jesem Douglas Yamall Orellana Geraldo Marcelo da Cunha Lihsieh Marrero Bernardo Lessa Horta Iuri da Costa Leite About the authors

Abstract

Manaus, the capital of the Brazilian State of Amazonas, is the current epicenter of the COVID-19 epidemic in Amazonia. The sharp increase in deaths is a huge concern for health system administrators and society. The study aimed to analyze excess overall mortality according to Epidemiological Week (EW) in order to identify changes potentially associated with the epidemic in Manaus. Overall and cause-specific mortality data were obtained from the Central Database of the National Civil Registry and the Mortality Information System for 2018, 2019, and 2020. The study analyzed age bracket, sex, place of death, EW, calendar year, and causes of death. Ratios were calculated between deaths in 2019/2018 and 2020/2019 to estimate excess deaths, with 5% confidence intervals. No significant excess overall mortality was seen in the ratios for 2019/2018, independently of EW. Meanwhile, the ratios for 2020/2019 increased from 1.0 (95%CI: 0.9-1.3) in EW 11 to 4.6 (95%CI: 3.9-5.3) in EW 17. Excess overall mortality was observed with increasing age, especially in individuals 60 years or older, who accounted for 69.1% (95%CI: 66.8-71.4) of the deaths. The ratios for 2020/2019 for deaths at home or on public byways were 1.1 (95%CI: 0.7-1.8) in EW 12 and 7.8 (95%CI: 5.4-11.2) in EW 17. The explosion in overall mortality in Manaus and the high proportion of deaths at home or on public byways reveals the epidemic’s severity in contexts of heavy social inequality and weak effectiveness of government policies, especially policies meant to deal with social inequalities and strengthen the Unified Health System.

Keywords:
COVID-19; Vulnerable Populations; Public Health Surveillance; Mortality


Introduction

As of May 20, 2020, two months after the World Health Organization (WHO) declared COVID-19 a pandemic, some five million cases and approximately 320,000 deaths had been reported in 216 countries/areas/territories. Even with strong evidence of underestimation of its official statistics 11. The Lancet. COVID-19 in Brazil: "so what?". Lancet 2020; 395:1461., Brazil is now the third most heavily affected country, with 280,000 cases and 18,000 deaths (World Health Organization. WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int/, accessed on 20/May/2020).

Distribution of COVID-19 mortality reflects Brazil’s social and geographic heterogeneity, with five states accounting for 81% of the deaths: São Paulo, Rio de Janeiro, Ceará, Pernambuco, and Amazonas, the latter having the highest proportion of infected individuals, with 10.6% (95%CI: 8.8-12.1) 22. Mellan TA, Hoeltgebaum HH, Mishra S, Whittaker C, Schnekenberg RP, Gandy A, et al. Estimating COVID-19 cases and reproduction number in Brazil. London: Imperial College London; 2020. (Report 21)..

The State of Amazonas is located in the Brazilian Amazonia, a region occupying approximately 60% of Brazil’s territory and whose population has been exposed historically to poverty and social inequality 33. Waisbich LT, Shankland A, Bloom G, Coelho VSP. Introduction. The accountability politics of reducing health inequalities: learning from Brazil and Mozambique. Novos Estudos CEBRAP 2019; 38:271-89.. A study on the Greater Metropolitan Area of Manaus identified extensive inequality in access to health services 44. Galvão TF, Tiguman GMB, Caicedo RM, Silva MT. Inequity in utilizing health services in the Brazilian Amazon: a population-based survey, 2015. Int J Health Plann Manage 2019; 34:e1846-53.. This is a common reality for populations living in remote areas and on indigenous lands 55. Ferrante L, Fearnside PM. Protect indigenous peoples from COVID-19. Science 2020; 368:251., whose social and economic vulnerability limits their mobility in the territory, making them more susceptible to the dramatic spread of COVID-19, especially in the more serious forms of the disease.

For more than four weeks, Manaus has shown signs of exhaustion of the public hospital network due to the rapid increase in COVID-19 cases. In the first two weeks of May alone, there were nearly 7,000 new cases, double the number identified until then. In addition, from April 19 to 28, the average daily number of burials in Manaus was 123, four times more than the daily average in the same period in 2019 66. Prefeitura de Manaus. Manaus registra quase 2,5 mil sepultamentos em abril. http://www.manaus.am.gov.br/noticia/manaus-registra-quase-25-mil-sepultamentos-em-abril/ (acessado em 10/Mai/2020).
http://www.manaus.am.gov.br/noticia/mana...
. The average daily number of COVID-19 deaths confirmed by health services during the same period was only 14, suggesting extensive underreporting, a problem seen elsewhere in the world, especially in places with precarious testing and deficient health services 77. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health 2020; 8:e480.,88. Castro MC, Carvalho LR, Chin T, Kahn R, Franca GV, Macario EM, et al. Demand for hospitalization services for COVID-19 patients in Brazil. medRxiv 2020; 1 abr. https://www.medrxiv.org/content/10.1101/2020.03.30.20047662v1.
https://www.medrxiv.org/content/10.1101/...
.

Despite uncertainties on COVID-19-specific mortality 99. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; [Online ahead of print]., indicators of excess deaths are one of the most objective and comparable parameters to assess the epidemic’s impact on mortality 1010. Leon DA, Shkolnikov VM, Smeeth L, Magnus P, Pechholdová M, Jarvis CI. COVID-19: a need for real-time monitoring of weekly excess deaths. Lancet 2020; 395:e81.. This study thus aimed to analyze excess overall mortality according to Epidemiological Week (EW) in order to identify changes in the risk of death potentially associated with the epidemic.

Methods

Study design and data sources

This was a cross-sectional study with mortality data from the Central Database of the National Civil Registry (National CRC. https://sistema.registrocivil.org.br) and the Mortality Information System (SIM. http://www2.datasus.gov.br).

Due to the pandemic scenario, the National CRC assembled a COVID-19 Registration Panel (Portal da Transparência. https://transparencia.registrocivil.org.br/registral-COVID, accessed on 10/May/2020), aimed at furnishing data on causes of death from Death Certificates recorded at notary public offices, which represents the totality of natural deaths, treated here as a proxy for general mortality. The data are updated daily and comply with legal guidelines and deadlines. The time between recording of the death and its transfer to the COVID-19 Registration Panel is 14 days or less, after which the data become public.

Working definitions

According to the National CRC criteria, a suspected or confirmed death from COVID-19 is one in which the death certificate mentions the terms COVID-19, coronavirus, or novel coronavirus in sections I (lines a, b, c, d) or II (other preexisting disease conditions not directly related to the death and not recorded in the causal sequence listed in part I). Besides COVID-19, other possible causes were considered based on the National CRC: severe acute respiratory syndrome (SARS); pneumonia; septicemia; and respiratory failure. Deaths not classified in any of the above-mentioned conditions were included in the category “other causes”. Finally, “indeterminate” deaths (causes of deaths related to respiratory causes, but inconclusive) accounted for fewer than 1% of the sample and were not presented separately.

The National CRC data were updated on May 19, 2020, 66 days after the start of EW 12 and 24 days after the last day of EW 17. The start of EW 12 corresponds to the two days after confirmation of the first case of COVID-19 and to the 15 days prior to the first death from COVID-19 in Manaus.

For purposes of comparison, we also used data on overall mortality from the SIM, furnished for the EW in question in 2018 in the city of Manaus.

Study variables

The study variables were age bracket, sex, death at home or on public byways, EW, calendar year, and causes of death. Deaths from SARS, pneumonia (PNM), and respiratory failure (RF) were aggregated in a variable called “SARS+PNM+RF”, which excludes the group of deaths suspected or confirmed by COVID-19 and according to the criteria of the National CRC.

Data analysis

We calculated the ratios between deaths in 2019 and 2018 (2019/2018) and in 2020 and 2019 (2020/2019), in EW 12 to 17 in Manaus. We also calculated the ratios between deaths in 2020/2019 in EW 14 to 17, stratified by sex, age bracket, and cause of death. For the mortality ratios, we calculated confidence intervals with 5% significance. The analyses were performed in the R program, version 3.6.1 (http://www.r-project.org).

Results

In 2018, according to the SIM, the mean weekly number of deaths in Manaus was 230, close to the weekly number observed in the first 70 days of 2019 and 2020 according to data from the National CRC, or 225 and 218 deaths, respectively.

As shown in Figure 1, the overall mortality ratio for 2019/2018 is very close to one, independently of EW, while the ratio 2020/2019 only showed a similar pattern (close to one) from EW 12 to 14, with a major increase in the subsequent weeks. In other words, the ratio increased from 1.0 (95%CI: 0.9-1.3) in EW 12 to 4.6 (95%CI: 3.9-5.3) in EW 17.

Figure 1
Overall mortality ratios for the years 2019/2018 and 2020/2019 by Epidemiological Week (EW). Manaus, Amazonas State, Brazil.

The overall mortality ratios for 2020/2019 according to age bracket were not statistically significant in males under 40 years of age or females under 30 years of age, revealing the excess mortality from those age brackets upwards in 2020, especially in males (Table 1).

Table 1
Overall mortality and respective ratios and confidence intervals for Epidemiological Weeks (EW) 14 to 17, according to age bracket and sex. Manaus, Amazonas State, Brazil.

When comparing the 2020/2019 mortality ratio according to groups of causes of death, the data showed a gradual increase over the weeks, especially starting in EW 15, for deaths from “SARS+PNM+RF” (Figure 2). In the group of “other causes”, the mortality ratio remained close to one until EW 14, when it increased, reaching a ratio of 3 by EW 17.

Figure 2
Mortality ratios by specific groups of causes for the years 2020/2019 by Epidemiological Week (EW). Manaus, Amazonas State, Brazil.

As for the distribution of deaths across age brackets, 69.1% of the deaths occurred in individuals 60 years or older (95%CI: 66.8-71.4). The ratio of deaths occurring at home or on public byways (43/38) in EW 12 was 1.1 (95%CI: 0.7-1.8). This same ratio (268/33) reached 8.1 (95%CI: 5.7-11.7) in EW 17 (data not shown).

Discussion

According to the results, total deaths reported in 2019 were similar to 2018, comparing EW 12 through 17 in those two years. However, the comparison between total deaths in 2020 and 2019 revealed excess mortality starting in the 15th EW of 2020, with the ratio exploding in EW 17, when the number of deaths was 200% higher than in 2019.

The increase in deaths started in EW 15, approximately 15 days after confirmation of the first 30 cases of COVID-19 in Manaus. In EW 17, the anomalous number of deaths coincided with the collapse in the public hospital system. During this period, the mean number of burials per day tripled. Deaths at home or on public byways also increased, as did COVID-19 cases in neighboring municipalities. This set of events probably resulted from a major acceleration in the epidemic in Manaus 1111. Programa de Pós-graduação em Ciências do Ambiente e Sustentabilidade na Amazônia, Universidade Federal do Amazonas. Atlas dos objetivos de desenvolvimento sustentável no Amazonas. (Especial COVID-19, 2). https://edoc.ufam.edu.br/handle/123456789/3198/ (acessado em 03/Mai/2020).
https://edoc.ufam.edu.br/handle/12345678...
in the previous weeks.

The fragility of the healthcare network in Manaus and in neighboring municipalities 44. Galvão TF, Tiguman GMB, Caicedo RM, Silva MT. Inequity in utilizing health services in the Brazilian Amazon: a population-based survey, 2015. Int J Health Plann Manage 2019; 34:e1846-53., combined with extensive social inequality 33. Waisbich LT, Shankland A, Bloom G, Coelho VSP. Introduction. The accountability politics of reducing health inequalities: learning from Brazil and Mozambique. Novos Estudos CEBRAP 2019; 38:271-89., help explain the critical situation with the COVID-19 epidemic. Excess mortality in the pandemic is not limited to low- and middle-income countries, but has also appeared in New York City, United States, and in the provinces of Bergamo and Brescia in northern Italy 99. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; [Online ahead of print].,1212. Weinberger D, Cohen T, Crawford F, Mostashari F, Olson D, Pitzer VE, et al. Estimating the early death toll of COVID-19 in the United States. medRxiv 2020; 29 abr. https://www.medrxiv.org/content/10.1101/2020.04.15.20066431v2.
https://www.medrxiv.org/content/10.1101/...
,1313. Ghislandi S, Muttarak R, Sauerberg M, Scotti B. News from the front: excess mortality and life expectancy in two major epicentres of the COVID-19 pandemic in Italy. medRxiv 2020; 13 mai. https://www.medrxiv.org/content/10.1101/2020.04.29.20084335v2.
https://www.medrxiv.org/content/10.1101/...
.

In relation to age, nearly 70% of the deaths occurred in persons 60 years or older, consistent with studies in other countries 99. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; [Online ahead of print].,1212. Weinberger D, Cohen T, Crawford F, Mostashari F, Olson D, Pitzer VE, et al. Estimating the early death toll of COVID-19 in the United States. medRxiv 2020; 29 abr. https://www.medrxiv.org/content/10.1101/2020.04.15.20066431v2.
https://www.medrxiv.org/content/10.1101/...
,1313. Ghislandi S, Muttarak R, Sauerberg M, Scotti B. News from the front: excess mortality and life expectancy in two major epicentres of the COVID-19 pandemic in Italy. medRxiv 2020; 13 mai. https://www.medrxiv.org/content/10.1101/2020.04.29.20084335v2.
https://www.medrxiv.org/content/10.1101/...
,1414. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; e200950.. In this age bracket, comorbidities are more prevalent and have been associated with worse prognosis in cases of hospitalization for COVID-19 1515. Dietz W, Santos-Burgoa C. Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring) 2020; 28:1005..

Another key aspect involves gender differences, with a higher risk of mortality among men, corroborating findings from other studies 1616. Ciminelli G, Garcia-Mandicó S. COVID-19 in Italy: an analysis of death registry data. VOX 2020; 22 abr. https://voxeu.org/article/covid-19-italy-analysis-death-registry-data.
https://voxeu.org/article/covid-19-italy...
,1717. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497-506.. Lower case-fatality may be associated with women’s heightened perception of the symptoms and search for health services, whereas men would only tend to turn to health services in the more serious stages of COVID-19, when therapeutic possibilities are more limited. However, Zeng et al. 1818. Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, et al. A comparison study of SARS-COV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying difference outcome between gender. medRxiv 2020; 27 mar. https://www.medrxiv.org/content/10.1101/2020.03.26.20040709v1.
https://www.medrxiv.org/content/10.1101/...
argued that higher IgG antibody levels in women could partially explain the relatively higher case-fatality in men.

There was an explosive increase in mortality from respiratory problems (SARS+PNM+RF), common complications of COVID-19 1414. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; e200950., during the COVID-19 pandemic. There was also a significant increase in mortality from other causes, possibly resulting from factors such as: the patient’s postponement of treatment in order to avoid exposure to the virus in hospitals, health services’ prioritization of care for COVID-19 1919. Vandoros S. Excess mortality during the COVID-19 pandemic: early evidence from England and Wales. medRxiv 2020; 17 mai. https://www.medrxiv.org/content/10.1101/2020.04.14.20065706v6.
https://www.medrxiv.org/content/10.1101/...
.

One strength of this study was the use of the overall mortality indicator to estimate excess deaths, which appears to be a useful resource for rapid and low-cost evaluations, besides serving as a more robust and comparable indicator in a pandemic scenario 1010. Leon DA, Shkolnikov VM, Smeeth L, Magnus P, Pechholdová M, Jarvis CI. COVID-19: a need for real-time monitoring of weekly excess deaths. Lancet 2020; 395:e81.. Unlike COVID-19-specific mortality, overall mortality does not depend on testing strategies, health systems’ organization and financing, demographic structure, or the choice of denominator, which can make the case-fatality estimates vary widely 99. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; [Online ahead of print].. However, the interpretation of this study’s results should take some limitations into account, such as the lack of standardization or review of the causes of death on the death certificates and a possible under-recording of deaths on the digital platform of the National CRC, especially in 2019, which could overestimate the ratios between total deaths in 2020 and 2019, for example. However, judging by the comparisons between total deaths in 2019 and 2018, where the ratios were always close to one, this distortion may possibly be small.

The analytical strategy adopted in this study unequivocally reveals the high excess mortality in Manaus and the epidemic’s severity in contexts of great social inequality, weak effectiveness of public policies, and fragility in health services. Efforts must be stepped up by administrators at the municipal, state, and federal levels to contain or mitigate the harmful effects of COVID-19, especially in more vulnerable areas where the pandemic tends to have a heavier impact on mortality.

References

  • 1
    The Lancet. COVID-19 in Brazil: "so what?". Lancet 2020; 395:1461.
  • 2
    Mellan TA, Hoeltgebaum HH, Mishra S, Whittaker C, Schnekenberg RP, Gandy A, et al. Estimating COVID-19 cases and reproduction number in Brazil. London: Imperial College London; 2020. (Report 21).
  • 3
    Waisbich LT, Shankland A, Bloom G, Coelho VSP. Introduction. The accountability politics of reducing health inequalities: learning from Brazil and Mozambique. Novos Estudos CEBRAP 2019; 38:271-89.
  • 4
    Galvão TF, Tiguman GMB, Caicedo RM, Silva MT. Inequity in utilizing health services in the Brazilian Amazon: a population-based survey, 2015. Int J Health Plann Manage 2019; 34:e1846-53.
  • 5
    Ferrante L, Fearnside PM. Protect indigenous peoples from COVID-19. Science 2020; 368:251.
  • 6
    Prefeitura de Manaus. Manaus registra quase 2,5 mil sepultamentos em abril. http://www.manaus.am.gov.br/noticia/manaus-registra-quase-25-mil-sepultamentos-em-abril/ (acessado em 10/Mai/2020).
    » http://www.manaus.am.gov.br/noticia/manaus-registra-quase-25-mil-sepultamentos-em-abril/
  • 7
    Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health 2020; 8:e480.
  • 8
    Castro MC, Carvalho LR, Chin T, Kahn R, Franca GV, Macario EM, et al. Demand for hospitalization services for COVID-19 patients in Brazil. medRxiv 2020; 1 abr. https://www.medrxiv.org/content/10.1101/2020.03.30.20047662v1
    » https://www.medrxiv.org/content/10.1101/2020.03.30.20047662v1
  • 9
    Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; [Online ahead of print].
  • 10
    Leon DA, Shkolnikov VM, Smeeth L, Magnus P, Pechholdová M, Jarvis CI. COVID-19: a need for real-time monitoring of weekly excess deaths. Lancet 2020; 395:e81.
  • 11
    Programa de Pós-graduação em Ciências do Ambiente e Sustentabilidade na Amazônia, Universidade Federal do Amazonas. Atlas dos objetivos de desenvolvimento sustentável no Amazonas. (Especial COVID-19, 2). https://edoc.ufam.edu.br/handle/123456789/3198/ (acessado em 03/Mai/2020).
    » https://edoc.ufam.edu.br/handle/123456789/3198/
  • 12
    Weinberger D, Cohen T, Crawford F, Mostashari F, Olson D, Pitzer VE, et al. Estimating the early death toll of COVID-19 in the United States. medRxiv 2020; 29 abr. https://www.medrxiv.org/content/10.1101/2020.04.15.20066431v2
    » https://www.medrxiv.org/content/10.1101/2020.04.15.20066431v2
  • 13
    Ghislandi S, Muttarak R, Sauerberg M, Scotti B. News from the front: excess mortality and life expectancy in two major epicentres of the COVID-19 pandemic in Italy. medRxiv 2020; 13 mai. https://www.medrxiv.org/content/10.1101/2020.04.29.20084335v2
    » https://www.medrxiv.org/content/10.1101/2020.04.29.20084335v2
  • 14
    Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; e200950.
  • 15
    Dietz W, Santos-Burgoa C. Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring) 2020; 28:1005.
  • 16
    Ciminelli G, Garcia-Mandicó S. COVID-19 in Italy: an analysis of death registry data. VOX 2020; 22 abr. https://voxeu.org/article/covid-19-italy-analysis-death-registry-data
    » https://voxeu.org/article/covid-19-italy-analysis-death-registry-data
  • 17
    Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497-506.
  • 18
    Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, et al. A comparison study of SARS-COV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying difference outcome between gender. medRxiv 2020; 27 mar. https://www.medrxiv.org/content/10.1101/2020.03.26.20040709v1
    » https://www.medrxiv.org/content/10.1101/2020.03.26.20040709v1
  • 19
    Vandoros S. Excess mortality during the COVID-19 pandemic: early evidence from England and Wales. medRxiv 2020; 17 mai. https://www.medrxiv.org/content/10.1101/2020.04.14.20065706v6
    » https://www.medrxiv.org/content/10.1101/2020.04.14.20065706v6

Publication Dates

  • Publication in this collection
    03 July 2020
  • Date of issue
    2020

History

  • Received
    12 May 2020
  • Reviewed
    21 May 2020
  • Accepted
    23 May 2020
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz Rio de Janeiro - RJ - Brazil
E-mail: cadernos@ensp.fiocruz.br